Highlights
NASDAQ: NKTR       Nektar Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
22.48   -1.42 (5.94%)  22.28 - 23.87  3,482,000

Overview

 
Avg Volume (4 weeks):3,333,526
4 Weeks Range:19.95 - 28.60
4 Weeks Price Volatility (%):
29.25%
52 Weeks Range:15.635 - 47.11
52 Weeks Price Volatility (%):
21.75%
Average Price Target: 17.00
Price Target Upside/Downside: -5.48

Headlines



No recent Headlines for this stock.


Business Background

Nektar Therapeutics Inc is a biopharmaceutical company that seeks to enable the development of new molecules to treat a number of therapeutic areas including oncology, pain, anti-infectives, and immunology. The company's research and development activities involve small-molecule drugs, peptides, and protein biologic drug candidates. The company decides on a candidate-by-candidate basis how far to advance clinical development and whether to commercialize products on its own, seek a partner, or pursue a combination of these approaches. Nektar's partnershipaims to fund continued clinical development, manage the regulatory filing process, and market and sell drugs in various geographies.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers